Intestinal microbiota, chronic inflammation, and colorectal cancer

Chan Hyuk Park; Chang Soo Eun; Dong Soo Han

doi:10.5217/ir.2018.16.3.338

Articles

Page Path: HOME > Intest Res > Volume 16(3); 2018 > Article

Focused Review: Colorectal Cancer Intestinal microbiota, chronic inflammation, and colorectal cancer: Chan Hyuk Park, Chang Soo Eun, Dong Soo Han; Intestinal Research 2018;16(3):338-345.
DOI: https://doi.org/10.5217/ir.2018.16.3.338
Published online: July 27, 2018

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

Correspondence to Dong Soo Han, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, 153 Gyeongchun-ro, Guri 11923, Korea. Tel: +82-31-560-2226, Fax: +82-31-553-7369, hands@hanyang.ac.kr

• Received: March 25, 2018 • Revised: May 3, 2018 • Accepted: May 3, 2018

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

10,340 Views
276 Download
75 Web of Science
73 Crossref
80 Scopus

Full Article

Download PDF

Abstract
INTRODUCTION
BACTERIAL TAXA ASSOCIATED WITH CRC
METHANOGENIC ARCHAEA AND CRC
MICROBIAL DISTRIBUTION AND ANATOMICAL DIFFERENCES
HOST-DIET INTERACTION
PERSPECTIVES
NOTES
REFERENCES

Abstract

In addition to genetic and epigenetic factors, various environmental factors, including diet, play important roles in the development of colorectal cancer (CRC). Recently, there is increasing interest in the intestinal microbiota as an environmental risk factor for CRC, because diet also influences the composition of the intestinal microbiota. The human intestinal microbiota comprises about 100 trillion microbes. This microbiome thrives on undigested dietary residues in the intestinal lumen and produces various metabolites. It is well known that the dietary risk factors for CRC are mediated by dysbiosis of the intestinal microbiota and their metabolites. In this review, we describe the bacterial taxa associated with CRC, including Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, Escherichia coli, and butyrate-producing bacteria. We also discuss the host-diet interaction in colorectal carcinogenesis.
Keywords: Microbiota; Colorectal neoplasms; Carcinogenesis; Inflammation

INTRODUCTION

Colorectal cancer (CRC) is the second most common cancer in women and the third most common cancer in men worldwide.1 CRC is regarded as a Westernized disease, as it has the highest incidence rates in North America, Australia, New Zealand, and Europe.2 However, over the last several decades, the incidence rates of CRC in the United States have been decreasing.3 This reduction is thought to be due to changes in the prevalence of risk factors and increased screening.4 In contrast, in Asian countries, including Korea, the incidence of CRC has been increasing in both men and women.5 6

CRC can develop via various pathways. More than 70% of CRC cases develop from premalignant adenomas in a multistep genetic process. Some forms of CRC are hereditary, but these represent less than 5% of total cases. In addition to genetic susceptibility, epigenetic mechanisms are also involved in colorectal carcinogenesis. For example, the epigenome of CRC usually has hundreds to thousands of abnormally methylated genes, and a subset of these are thought to initiate the development of CRC.7 In additional to genetic and epigenetic factors, the intestinal microbiota is increasingly recognized as a confounding factor in the development of CRC. Finally, other environmental factors, such as diet, also play an important role in the development of CRC.8 For example, high dietary fiber intake is associated with a reduced risk of CRC, while high intake of red meat and processed meat is associated with an increased risk of CRC.9 10 The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), reported the risk of excessive consumption of red meat and processed meat.11 A study on colon cancer risk in Japanese immigrants showed progressive changes in the incidence of colon cancer among Japanese after migrating to Hawaii.12 Such evidence supports a strong relationship between diet and the development of CRC.

Recently, interest in the intestinal microbiota as an environmental factor for CRC has increased, because diet also influences the composition of the intestinal microbiota. The human intestinal microbiota is a community of approximately 100 trillion microbes13 that thrives on the undigested dietary residues in the intestinal lumen and produces various metabolites. It is well known that the dietary risk of CRC is mediated by dysbiosis of the intestinal microbiota and their metabolites.14 The relationship between diet and intestinal bacteria was also demonstrated in a metagenome-wide association study. High intake of red meat relative to fruits and vegetables was shown to be associated with the outgrowth of bacteria that may contribute to a more hostile gut environment.15 In addition, it has been shown that there are similar bacterial networks on oral and colonic mucosal surfaces, in both individuals with colonic lesions (on and off the tumor) and healthy controls.16 These findings support the notion that colonic bacteria may be derived from dietary food and oral bacteria.

BACTERIAL TAXA ASSOCIATED WITH CRC

There are few data showing that the intestinal microbiota directly induce CRC. However, it has been suggested that some bacteria have a pivotal role of the development of CRC. It has been shown that Fusobacterium nucleatum is associated with intestinal tumorigenesis and modulates the tumor-immune microenvironment.17 Many case-control studies have demonstrated that the abundance of F. nucleatum was higher in patients with CRC than in controls.18 19 20 21 In addition, several studies have reported that F. nucleatum is associated with colorectal adenoma rather than CRC.22 23 Patients with CRC harboring F. nucleatum in their mucosa have more advanced disease and poorer prognosis, which is associated with the response to chemotherapeutic agents. F. nucleatum can affect host immunity through its attachment to epithelial cells via Fusobacterium adhesion A (FadA),24 and its recognition of the Gal-GalNAc portion of the membrane by the lectin Fap2.25 These interactions lead to bacterial adhesion and invasion, as well as an altered immune response to bacterial infection, via decreased apoptosis, cellular proliferation, and DNA repair, through activation of the nuclear factor-κB(NF-κB) and Wnt signaling pathways. Increased expression of LC3-II mediated by F. nucleatum induces the expression of autophagy-related proteins.26 This affects host immune surveillance and orchestrates Toll-like receptors, microRNAs, and the autophagy network to control cancer chemo-resistance. As a result, in CRC patients that harbor F. nucleatum, the cancer frequently recurs after drug therapy.26 In addition, F. nucleatum produces a protein that binds to an immunoreceptor on T and natural killer cells and blocks their cytotoxic activity against tumor cells.27

Fecal transfer from mice with CRC promotes colon carcinogenesis. In a recent study of fecal transfer from mice with CRC to healthy mice, F. nucleatum and Peptostreptococcus anaerobius were relatively abundant.28 After fecal transfer, increases in the number of polyps and the levels of cellular dysplasia, epithelial proliferation, inflammatory markers, and Th1 and Th17 cells were noted. These findings indicate that the intestinal microbiota has a strong influence on host immunity via cross-talk. Microbes like F. nucleatum may affect the development of CRC through the metabolites they produce, such as the short chain fatty acid (SCFA). SCFAs, principally butyrate, propionate, and acetate, have a remarkable array of colonic health-promoting and antineoplastic effects.29 30 Although the detailed mechanism of F. nucleatum-driven CRC development via butyrate metabolism is not well understood, a metagenome-wide association study detected butyryl-CoA dehydrogenase from F. nucleatum as a genetic marker for CRC.31 Colorectal carcinogenesis is accompanied by rupture and bleeding of the cancerous tissue, which alters the microenvironment and puts selective pressure on the local microorganisms.32 These changes facilitate the gradual replacement of the typical commensal intestinal microorganisms by F. nucleatum.

In addition to F. nucleatum, a variety of other bacteria are associated with CRC in mice. For example, enterotoxigenic Bacteroides fragilis (ETBF), polyketide synthase (pks) NC101 Escherichia coli, Streptococcus gallolyticus, and Enterococcus faecalis have been shown to promote the development of CRC in in vitro studies. Bacteroides is an abundant microorganism in the intestine of patients with CRC. ETBF encodes a specific virulence factor, the 21 kDa B. fragilis toxin, that cleaves E-cadherin on the host epithelium, affects epithelial permeability, and causes intestinal inflammation.33 In a pyrosequencing analysis, although the absolute abundance of bacteria per gram of stool in CRC patients and healthy individuals was similar, the abundance of Bacteroides was higher in patients with CRC than in healthy individuals.34 In addition, an operational taxonomic unit (OTU) closely related to B. fragilis was enriched in the gut microbiome of CRC patients.35 Another study showed that the abundance of Bacteroides was increased in colorectal adenoma.36 ETBF secretes an enterotoxin that functions as a zinc-dependent metalloprotease and causes DNA damage.37 In apc-deficient mice, this enterotoxin leads to interleukin 17 (IL-17)-dependent inflammation and induces the development of distal CRC. Additionally, infection with ETBF causes chronic colitis, with robust and rapid colonic activation of signal transducer and activator of transcription 3 (STAT3).38 39 ETBF also increased the number of adenomas in early stage CRC in a mouse model. Based on these findings, several OTUs from Bacteroides have been implicated as microbial biomarkers for the prediction of colorectal neoplasia.36 In fact, the combination of metagenome analysis and the fecal occult blood test (FOBT) increased the sensitivity for the prediction of CRC by 45% compared to FOBT alone.19

Some strains of E. coli detected in CRC are more invasive than the strains observed in other diseases. For example, E. coli harboring pks islands, which are more common in CRC than are bacteria that do not have pks islands,40 produce colibactin, a genotoxic metabolite (encoded by pks island) that promotes SUMO-conjugation to p53 tumor suppressor protein and cell senescence.33 41 Thereafter, it induces hepatocyte growth factor production and enhanced tumor cell proliferation.33 41 In mouse enterocytes, infection with pks⁺ E. coli resulted in DNA damage.42 Mono-colonization of carcinogen-treated IL-10-deficient mice with E. coli harboring pks islands induced the development of invasive CRC.40 In addition, the pks island has been shown to be required for tumorigenesis in the gut.40 43

Another species, S. gallolyticus, which was formerly known as Streptococcus bovis, is well-known to be involved in cases of bacterial endocarditis associated with CRC. Approximately 18% of patients who were infected with S. gallolyticus (most of whom had infective endocarditis) had CRC.44 When colorectal adenoma or cancer develops, distortion of the colonic mucosa may allow bacteria, such as S. gallolyticus, to access the previously unexposed collagen fibers in the basement membrane.45

As mentioned above, various bacterial taxa have been shown to be associated with CRC. These findings have been supported by a metagenome-wide association study.15 In the study, approximately 59% of the gene markers were significantly more abundant in CRC when compared with both controls and advanced adenomas. Another 24.3% of the genes were significantly elevated when compared with the controls. In contrast, only 4.1% of genes were significantly decreased in CRC when compared with the controls and advanced adenomas. This disparity in the number of increasing and decreasing genes suggests that the increase in pathobionts is more pronounced than the decrease in beneficial bacteria in colorectal carcinogenesis.15

Some bacterial taxa are associated with a lower risk of CRC. For instance, butyrate-producing bacteria, including Lachnospiraceae and Clostridium, are thought to be negatively associated with CRC. Through 16S rRNA gene sequencing analysis, Roseburia and other butyrate-producing bacteria of the family Lachnospiraceae and genus Clostridium were shown to be less abundant in patients with CRC.35 36 These bacterial taxa are well known producers of SCFAs in the colon.36 SCFAs are the preferred energy substrate for colonic cells, and they help maintain epithelial health and homeostasis.36 46 Additionally, butyrate has substantial anti-tumorigenesis effects, including inhibition of tumor cell proliferation, initiation of apoptosis in tumor cells, and mediation of T-regulatory cell homeostasis.47 48 Loss of butyrate-producing bacteria and enrichment of pathogenic bacteria may have synergistic effects on tumorigenesis.36

The numbers of lactic acid-producing bacteria, such as Bifidobacterium animalis and Streptococcus thermophilus, are decreased in feces from patients with colorectal adenoma or cancer.15 The lactic acid produced by these bacteria may increase intraluminal acidity in the colon and inhibit amino acid degradation.49 50 Lactic acid-producing bacteria, including Bifidobacterium, have been shown to stimulate the generation of nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) 1-dependent reactive oxygen species and intestinal stem cell proliferation.51 In addition, lactic acid accelerates turnover of the colonic epithelium in starvation-refed mice.52 In patients with a lower abundance of lactic acid-producing bacteria, this daily renewal of the colon epithelial cells may be prevented, allowing potential pathogens to grow.

Although many studies have demonstrated an association between certain bacteria and the development of CRC, not all studies have yielded consistent results.53 Several studies suggested Fusobacteria as an abundant bacterial taxon in patients with CRC, while other studies identified Bacteroides as the major bacterial taxon associated with CRC.53 In addition, it is unlikely that there is only one key player in the development of CRC. Therefore, there have been attempts to classify the bacteria that affect CRC development using clustering methods. Flemer et al.54 divided identified bacterial taxa into Pathogen cluster, Bacteroides cluster 1, Bacteroides cluster 2, Firmicutes cluster 1, Firmicutes cluster 2, and Prevotella cluster. In the study, the pathogen cluster consisted of Fusobacterium, Parvimonas, and Peptostreptococcus, while butyrate-producing bacteria, such as Clostridium, were included in the Firmicutes clusters.

METHANOGENIC ARCHAEA AND CRC

Methanogenic archaea is identified in about 25% to 40% of children and 42% to 82% of adults.55 56 It the colon of healthy individuals, methanogenic archaea can constitute up to 10% of all anaerobes.57 However, it can also play a role of pathogen in the colorectal carcinogenesis. Although the mechanism is still doubt, it seemed to be associated with a microbial shift towards an anaerobic consortium, consisting of saccharolytic and proteolytic anaerobic bacteria, including Clostridium, Eubacterium, the Bacteroides/Prevotella cluster, the terminal-degrading methanogens, and sulfate-reducing bacteria, with a concomitant reduction in probiotic bacteria.58

MICROBIAL DISTRIBUTION AND ANATOMICAL DIFFERENCES

The intestinal epithelium is covered by mucus layer. The mucus in the large intestine is divided into a 2-layered structure composed mainly of the mucin MUC2.59 The inner mucus layer is very dense, free of bacteria, and plays a role in preventing the invasion of microbes into the epithelial cells. The outer mucus layer is very thick and is heavily colonized by resident bacteria.60 Mucin glycan plays a key role in controlling the microbial community.61 Bacterial mucin glycan catabolism is important for gut colonization, and unexpected changes in mucin-degrading bacteria may interrupt gut homeostasis.61 Intestinal mucus is closely related to diet, and in mice, a low-fiber diet accelerates degradation of mucus glycan and weakens this layer.62 Biofilms generated by resident microbiota can modify epithelial cell biology and are associated with the initiation and progression of CRC.63 Much greater biofilm growth is detected in colon cancer tissues, especially in proximal colon cancer tissues. Bacterial biofilm formation triggers prolonged activation of inflammation.64 Although various mechanisms regarding biofilm formation and CRC have been proposed and are currently unproven, evidence suggests that biofilm formation and its association with intestinal dysbiosis may be an initial process in colorectal carcinogenesis.65

Based on the overwhelming burden of microbial biofilms in the colon proximal to the hepatic flexure, Dejea et al.63 proposed redefining the proximal colon as the cecum, ascending colon, and hepatic flexure. In addition, the microbial load and levels of metabolites such as SCFAs also differ between proximal and distal CRCs.66 A study of 1,102 CRCs using quantitative PCR found that the proportion of F. nucleatum-high CRCs gradually increased according to location (2.5% for rectal cancers to 11% for cecal cancers), with a statistically significant linear trend along all subsites.67 These differences in microbial distribution and biofilms may lead to molecular differences in the development of CRCs between the proximal and distal colon.

HOST-DIET INTERACTION

Despite the known association between F. nucleatum and CRC, there is no evidence that F. nucleatum is involved in the early stage of colorectal carcinogenesis. Multiple bacteria that compete for luminal nutrients, rather than a single bacterium, may influence the development of CRC. Therefore, more studies are needed to identify the causative roles of the microbiota in colon carcinogenesis in humans.

Lifestyle and metabolic diseases are well-known risk factors for CRC. Diet affects the composition of the gut microbiota, and dysbiosis has been shown to be associated with various diseases, such as obesity, IBD, colon cancer, and so forth. Longstanding diet habits can change the microbiota and lead to defects in the inner mucus layer and compromised epithelial integrity. Such altered epithelial integrity allows translocation of bacteria and diffusion of microbiotaderived metabolites. These microbes ferment undigested intraluminal fibers as an energy source and produce SCFAs, which are essential for epithelial cell homeostasis. SCFAs also control microRNA expression and histone deacetylation. Changes in histone deacetylation can alter cell cycle regulation.68 SCFAs also have anti-inflammatory and anti-neoplastic activities in mice, which are mediated by down-regulation of Wnt signaling and induction of apoptosis.69 Patients with CRC show low SCFAs and diminished levels of fecal butyrate and butyrate-producing bacteria.35 70

A high-fat diet, which is a common Western-style diet, is closely related to bile acid metabolism. A diet high in saturated fat enhances taurine conjugation and induces the expansion of sulfite-reducing Bilophila wadsworthia. It also exacerbates colitis in IL-10-knockout mice.71 Bile acid levels are controlled by the enterohepatic circulation, and bacterial conjugation in the intestine is a major limiting step. Therefore, alteration of the microbiota composition, so called dysbiosis, increases bacterial conjugation and secondary bile acids via the enterohepatic circulation. Increased secondary bile acids produce reactive oxygen and induce the NF-κB signaling pathway in the intestinal epithelium, resulting in cell damage and cell proliferation.72 Sulfate-reducing bacteria produce hydrogen sulfide as a byproduct of fermentation, which shows genotoxicity.73 B. wadsworthia uses taurine and generates hydrogen sulfide as an end-product. Hydrogen sulfide induces DNA damage and a pro-inflammatory response in the host. In addition to B. wadsworthia, it has been known that various sulfate-reducing bacteria including Desulfovibrio, Desulfomonas, Desulfobacter, and Desulfococcus may be associated with CRC.74 They use lactate, pyruvate, or acetate as an energy source during the reduction of sulfate to hydrogen sulfide.74

In addition, the gut microbiota can influence the mucosal barrier by altering the mucus layer in the intestine. The Western-style diet was shown to alter epithelial permeability and the growth rate of the inner mucus layer in mice.62

PERSPECTIVES

The pathogenesis of CRC is heterogeneous, and has been shown to involve various elements, including genetic susceptibility, host immunity, environmental factors, and the intestinal microbiota (Fig. 1). The intestinal microbiota can influence colorectal carcinogenesis in various ways, by promoting sustained inflammation, impairing host immunity, directly damaging DNA with genotoxins, and altering metabolic activity. Although there is little evidence that the microbiota can induce CRC in humans, results from a F. nucleatum-association study shows strong crosstalk between the intestinal microbiota and the host immune system.

Most cases of CRC are sporadic, and F. nucleatum may play a role in a late stage of the adenoma-carcinoma sequence. Therefore, it is important to identify the early events in colorectal carcinogenesis. Some bacteria, such as ETBF, induce colon polyps and CRC in the early stage of colorectal carcinogenesis. It is well known that diet affects the intestinal microbiota, and there is growing evidence showing that diet is related to the development of CRC. Long-term intake of a high-fat, low-fiber diet induces dysbiosis and makes the intestinal mucus barrier more vulnerable, leading to changes in the intestinal bacterial composition and stimulation of epithelial cells or the mucosal immune system against intestinal bacteria. In addition, following the change in microbiota composition due to alteration of the mucus layer, reciprocally, the intestinal mucosa becomes even more vulnerable, resulting in DNA damage to the epithelial cells in colorectal adenoma and cancer through the classic adenoma-carcinoma sequence. However, it is uncertain whether dysbiosis precedes the change in epithelial integrity, including the mucus layer, or it happens independently. In addition, both condition have reciprocal effects. Therefore, the conditions associated with dysbiosis may be an initial step in colorectal carcinogenesis. The crosstalk described above will be useful for further promoting the use of colonoscopy, which will affect the prognosis of patients with CRC.

NOTES

FINANCIAL SUPPORT: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1A2B6004475).

CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS: C.H.P. and D.S.H. drafted the article. C.S.E. provided a critical revision of manuscript. All authors approved the final version of the article.

REFERENCES

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.PMID: 25651787.Article PubMed
2. Perdue DG, Haverkamp D, Perkins C, Daley CM, Provost E. Geographic variation in colorectal cancer incidence and mortality, age of onset, and stage at diagnosis among American Indian and Alaska Native people, 1990-2009. Am J Public Health 2014;104(Suppl 3): S404–S414.PMID: 24754657.Article PubMed PMC
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7–30.PMID: 26742998.Article PubMed
4. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst 2017;109PMID: 10.1093/jnci/djw322.Article PMC PDF
5. Ng SC, Wong SH. Colorectal cancer screening in Asia. Br Med Bull 2013;105:29–42.PMID: 23299409.Article PubMed PDF
6. Shin A, Kim KZ, Jung KW, et al. Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res Treat 2012;44:219–226.PMID: 23341785.Article PubMed PMC PDF
7. Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011;8:686–700.PMID: 22009203.Article PubMed PMC PDF
8. Hughes LA, Simons CC, van den Brandt PA, van Engeland M, Weijenberg MP. Lifestyle, diet, and colorectal cancer risk according to (epi)genetic instability: current evidence and future directions of molecular pathological epidemiology. Curr Colorectal Cancer Rep 2017;13:455–469.PMID: 29249914.Article PubMed PMC PDF
9. Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011;343:d6617. PMID: 10.1136/bmj.d6617. PMID: 22074852.Article PubMed PMC
10. Magalhães B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev 2012;21:15–23.PMID: 21946864.Article PubMed
11. IARC monographs evaluate consumption of red meat and processed meat. International Agency for Research on Cancer Web site Accessed Mar 1, 2018. https://www.iarc.fr/en/media-centre/pr/2015/pdfs/pr240_E.pdf.
12. Le Marchand L, Kolonel LN. Cancer in Japanese migrants to Hawaii: interaction between genes and environment. Rev Epidemiol Sante Publique 1992;40:425–430.PMID: 1287741.PubMed
13. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207–214.PMID: 22699609.Article PubMed PMC
14. Vipperla K, O'Keefe SJ. Diet, microbiota, and dysbiosis: a ‘recipe’ for colorectal cancer. Food Funct 2016;7:1731–1740.PMID: 26840037.Article PubMed PMC
15. Feng Q, Liang S, Jia H, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 2015;6:6528PMID: 25758642.Article PubMed PDF
16. Flemer B, Warren RD, Barrett MP, et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut 2018;67:1454–1463.PMID: 28988196.Article PubMed
17. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013;14:207–215.PMID: 23954159.Article PubMed PMC
18. Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105:1907–1911.PMID: 24316595.Article PubMed PMC PDF
19. Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766PMID: 25432777.Article PubMed PMC
20. Vogtmann E, Hua X, Zeller G, et al. Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS One 2016;11:e0155362. PMID: 10.1371/journal.pone.0155362. PMID: 27171425.Article PubMed PMC
21. Liang Q, Chiu J, Chen Y, et al. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clin Cancer Res 2017;23:2061–2070.PMID: 27697996.Article PubMed
22. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One 2013;8:e53653. PMID: 10.1371/journal.pone.0053653.PMID: 23335968.Article PubMed PMC
23. Park CH, Han DS, Oh YH, Lee AR, Lee YR, Eun CS. Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis. Sci Rep 2016;6:25271. PMID: 27125587.Article PubMed PMC PDF
24. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14:195–206.PMID: 23954158.Article PubMed PMC
25. Abed J, Emgård JE, Zamir G, et al. Fap2 Mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 2016;20:215–225.PMID: 27512904.Article PubMed PMC
26. Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 2017;170:548–563.e16.PMID: 28753429.Article PubMed PMC
27. Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 2015;42:344–355.PMID: 25680274.Article PubMed PMC
28. Wong SH, Zhao L, Zhang X, et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology 2017;153:1621–1633.e6.PMID: 28823860.Article PubMed
29. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661–672.PMID: 25198138.Article PubMed PDF
30. Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 2008;19:587–593.PMID: 18061431.Article PubMed
31. Yu J, Feng Q, Wong SH, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 2017;66:70–78.PMID: 26408641.Article PubMed
32. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driverpassenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012;10:575–582.PMID: 22728587.Article PubMed PDF
33. Chen J, Pitmon E, Wang K. Microbiome, inflammation and colorectal cancer. Semin Immunol 2017;32:43–53.PMID: 28982615.Article PubMed
34. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011;6:e16393. PMID: 10.1371/journal.pone.0016393. PMID: 21297998.Article PubMed PMC
35. Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012;6:320–329.PMID: 21850056.Article PubMed PDF
36. Zackular JP, Rogers MA, Ruffin MT 4th, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) 2014;7:1112–1121.PMID: 25104642.Article PubMed PMC
37. Sears CL, Islam S, Saha A, et al. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis 2008;47:797–803.PMID: 18680416.Article PubMed PMC PDF
38. O'Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 2016;13:691–706.PMID: 27848961.Article PubMed PMC PDF
39. Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009;15:1016–1022.PMID: 19701202.Article PubMed PMC PDF
40. Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120–123.PMID: 22903521.Article PubMed PMC
41. Cougnoux A, Dalmasso G, Martinez R, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 2014;63:1932–1942.PMID: 24658599.Article PubMed
42. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 2010;107:11537–11542.PMID: 20534522.Article PubMed PMC
43. Tomkovich S, Yang Y, Winglee K, et al. Locoregional effects of microbiota in a preclinical model of colon carcinogenesis. Cancer Res 2017;77:2620–2632.PMID: 28416491.Article PubMed PMC
44. Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 2011;53:870–878.PMID: 21960713.Article PubMed PDF
45. Boleij A, Muytjens CM, Bukhari SI, et al. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis 2011;203:1101–1109.PMID: 21451000.Article PubMed PDF
46. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008;27:104–119.PMID: 17973645.Article PubMed
47. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 2003;52:94–100.PMID: 12477768.Article PubMed PMC
48. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569–573.PMID: 23828891.Article PubMed
49. Smith EA, Macfarlane GT. Enumeration of amino acid fermenting bacteria in the human large intestine: effects of pH and starch on peptide metabolism and dissimilation of amino acids. FEMS Microbiol Ecol 1998;25:355–368.Article PDF
50. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 1996;81:288–302.PMID: 8810056.Article PubMed
51. Jones RM, Luo L, Ardita CS, et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 2013;32:3017–3028.PMID: 24141879.Article PubMed PMC
52. Okada T, Fukuda S, Hase K, et al. Microbiota-derived lactate accelerates colon epithelial cell turnover in starvation-refed mice. Nat Commun 2013;4:1654PMID: 23552069.Article PubMed PDF
53. Song M, Chan AT. Diet, gut microbiota, and colorectal cancer prevention: a review of potential mechanisms and promising targets for future research. Curr Colorectal Cancer Rep 2017;13:429–439.PMID: 29333111.Article PubMed PMC PDF
54. Flemer B, Lynch DB, Brown JM, et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 2017;66:633–643.PMID: 26992426.Article PubMed
55. Stewart JA, Chadwick VS, Murray A. Carriage, quantification, and predominance of methanogens and sulfate-reducing bacteria in faecal samples. Lett Appl Microbiol 2006;43:58–63.PMID: 16834722.Article PubMed
56. Hudson MJ, Tomkins AM, Wiggins HS, Drasar BS. Breath methane excretion and intestinal methanogenesis in children and adults in rural Nigeria. Scand J Gastroenterol 1993;28:993–998.PMID: 8284637.Article PubMed
57. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635–1638.PMID: 15831718.Article PubMed PMC
58. Matarazzo F, Ribeiro AC, Faveri M, Taddei C, Martinez MB, Mayer MP. The domain Archaea in human mucosal surfaces. Clin Microbiol Infect 2012;18:834–840.PMID: 22827611.Article PubMed
59. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008;105:15064–15069.PMID: 18806221.Article PubMed PMC
60. Fung TC, Artis D, Sonnenberg GF. Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol Rev 2014;260:35–49.PMID: 24942680.Article PubMed PMC
61. Tailford LE, Crost EH, Kavanaugh D, Juge N. Mucin glycan foraging in the human gut microbiome. Front Genet 2015;6:81PMID: 25852737.Article PubMed PMC
62. Schroeder BO, Birchenough GMH, Ståhlman M, et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe 2018;23:27–40.e7.PMID: 29276171.Article PubMed
63. Dejea CM, Wick EC, Hechenbleikner EM, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A 2014;111:18321–18326.PMID: 25489084.Article PubMed PMC
64. Li S, Konstantinov SR, Smits R, Peppelenbosch MP. Bacterial biofilms in colorectal cancer initiation and progression. Trends Mol Med 2017;23:18–30.PMID: 27986421.Article PubMed
65. Johnson CH, Dejea CM, Edler D, et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab 2015;21:891–897.PMID: 25959674.Article PubMed PMC
66. Drewes JL, Housseau F, Sears CL. Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy. Br J Cancer 2016;115:273–280.PMID: 27380134.Article PubMed PMC PDF
67. Mima K, Cao Y, Chan AT, et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol 2016;7:e200. PMID: 10.1038/ctg.2016.53. PMID: 27811909.Article PubMed PMC PDF
68. Fellows R, Denizot J, Stellato C, et al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat Commun 2018;9:105PMID: 29317660.Article PubMed PMC PDF
69. Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014;40:128–139.PMID: 24412617.Article PubMed PMC
70. Hu Y, Le Leu RK, Christophersen CT, et al. Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. Carcinogenesis 2016;37:366–375.PMID: 26905582.Article PubMed PDF
71. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012;487:104–108.PMID: 22722865.Article PubMed PMC PDF
72. Bernstein C, Holubec H, Bhattacharyya AK, et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 2011;85:863–871.PMID: 21267546.Article PubMed PMC
73. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbialpathways in colonic sulfur metabolism and links with health and disease. Front Physiol 2012;3:448PMID: 23226130.Article PubMed PMC
74. Irrazábal T, Belcheva A, Girardin SE, Martin A, Philpott DJ. The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell 2014;54:309–320.PMID: 24766895.Article PubMed

Fig. 1

The proposed pathogenesis of colorectal carcinogenesis. MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor-κB; PI3K/AKT, phosphoinositide 3-kinase/protein kinase B; TNF-α, tumor necrosis factor α; IL, interleukin.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

5‐Fluorouracil Loaded Prebiotic–Probiotic Liposomes Modulating Gut Microbiota for Improving Colorectal Cancer Chemotherapy
Xujie Sun, Xiaoting Shan, Binyu Zhu, Ying Cai, Zongyan He, Lingli Zhou, Lixuan Yin, Yiran Liu, Kaiyue Liu, Tian Zhang, Ning Yang, Yaping Li, Tianqun Lang
Advanced Healthcare Materials.2025;[Epub] CrossRef
Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment
Weiqiang Huang, Tao Jiang, Jiaxuan He, Jing Ruan, Baihui Wu, Runchao Tao, Peiye Xu, Yongpan Wang, Rongbing Chen, Hanbing Wang, Qinsi Yang, Kun Zhang, Libo Jin, Da Sun, Jinfeng You
Probiotics and Antimicrobial Proteins.2025; 17(3): 1038. CrossRef
Gut microbiome and colorectal cancer: From pathogenesis to treatment
Masoud Lahouty, Manouchehr Fadaee, Reza Aghaei, Fatemeh Alizadeh, Amirmohammad Jafari, Yaeghob Sharifi
Pathology - Research and Practice.2025; 271: 156034. CrossRef
Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer
Ceren Acar, Sibel Kucukyildirim Celik, H. Ozgur Ozdemirel, Beril Erdem Tuncdemir, Saadet Alan, Hatice Mergen
Folia Microbiologica.2024; 69(2): 333. CrossRef
Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies
Hammad Naeem, Hammad Ul Hassan, Muhammad Shahbaz, Muhammad Imran, Anjuman Gul Memon, Ammarah Hasnain, Shamas Murtaza, Suliman A. Alsagaby, Waleed Al Abdulmonem, Muzzamal Hussain, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Entessar Al Jbawi, Rafik Balti
Journal of Food Biochemistry.2024; 2024: 1. CrossRef
The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
Aldona Kasprzak, Agnieszka Geltz
Biomedicines.2024; 12(3): 578. CrossRef
Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients
Nayoung Han, Hee Jin Chang, Hyun Yang Yeo, Byung Chang Kim, Bun Kim, Sung Chan Park, Jeongseon Kim, Ji Won Park, Jae Hwan Oh
Pathology.2024; 56(4): 528. CrossRef
The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
Hadas Ashkenazi-Preiser, Or Reuven, Atara Uzan-Yulzari, Sharon Komisarov, Roy Cirkin, Sondra Turjeman, Carmel Even, Nira Twaik, Kerem Ben-Meir, Ivan Mikula, Leonor Cohen-Daniel, Yaron Meirow, Eli Pikarsky, Yoram Louzoun, Omry Koren, Michal Baniyash
Cancer Research Communications.2024; 4(4): 1063. CrossRef
A Potential Role of Xenometabolites as Nutraceutical: A Concurrent Review
Sunanda Biswas, Ali Imran, Fakhar Islam, Muhammad Umair Arshad, Iqra Aslam, Mohd Asif Shah, Umber Shehzadi, Ifrah Usman, zza Faiz UL Rasool, Safura Aslam
Current Research in Nutrition and Food Science Journal.2024; 12(1): 20. CrossRef
TLR4/NF-kB/β-Catenin/TGF-β pathways in Salmonella AvrA related-Colorectal Cancer Tumorigenesis
Bogi Pratomo Wibowo, Handono Kalim, Husnul Khotimah, Hidayat Sujuti, Ettie Rukmigarsari
Research Journal of Pharmacy and Technology.2024; : 2597. CrossRef
Association of Helicobacter pylori infection with colorectal polyps/adenomas: A single-center cross-sectional study
Lan Chen, Rongrong Cao, Jie Han, Honglu Yu, Yingchao Li, Xiaomin Wang, Jiang Chen, Xingshun Qi
Cancer Epidemiology.2024; 92: 102626. CrossRef
Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis
Luping Chen, Linfang Zhang, Hua Hua, Li Liu, Yuejian Mao, Ruirui Wang
Immunity, Inflammation and Disease.2024;[Epub] CrossRef
Collective neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio symbolizes a new prognostic factor in the survival of gastric cancer patients
Sareh Mohammadi, Zeinab Veisi, Mohammad Moazeni, Soleiman Kheiri, Zahra Lorigooini, Roholah Masomi
Journal of Shahrekord University of Medical Sciences.2024; 26(2): 51. CrossRef
ChanLingGao alleviates intestinal mucosal barrier damage and suppresses the onset and progression of Colorectal cancer in AOM/DSS murine model
Ting-ting Tian, Guo Chen, Kai Sun, Xiao-yi Wang, Yang Liu, Fei-qing Wang, Bing Yang, Jian Liu, Jing-Yan Han, Dong-xin Tang
International Immunopharmacology.2024; 143: 113193. CrossRef
Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia
Aldona Kasprzak
International Journal of Molecular Sciences.2023; 24(4): 3665. CrossRef
The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens
Matthew T. F. Lamaudière, Ramesh Arasaradnam, Gareth D. Weedall, Igor Y. Morozov, Vincent B. Young
mSphere.2023;[Epub] CrossRef
Bacteroides fragilis Toxin Induces Cleavage and Proteasome Degradation of E-cadherin in Human Breast Cancer Cell Lines BT-474 and MCF7
Da-Hye KANG, Sang-Hyeon YOO, Ju-Eun HONG, Ki-Jong RHEE
Korean Journal of Clinical Laboratory Science.2023; 55(1): 37. CrossRef
Editorial: Targeting the microbiota to attenuate chronic inflammation
Elena Moreno, Marius Trøseid, Ivan Vujkovic-Cvijin, Giulia Marchetti, Laura Martín-Pedraza, Sergio Serrano-Villar
Frontiers in Immunology.2023;[Epub] CrossRef
Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression
Jia-Jie Zhu, Hai-Yan Liu, Liang-Jun Yang, Zheng Fang, Rui Fu, Jia-Bin Chen, Shan Liu, Bao-Ying Fei
Journal of Medical Microbiology .2023;[Epub] CrossRef
Disease‐associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer
Hongze Zhang, Kai Jin, Kunlong Xiong, Wenwen Jing, Zhen Pang, Meng Feng, Xunjia Cheng
Cancer Medicine.2023; 12(14): 15720. CrossRef
Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets
Nikolay Shakhpazyan, Liudmila Mikhaleva, Arkady Bedzhanyan, Zarina Gioeva, Nikolay Sadykhov, Alexander Mikhalev, Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann, Alexander Orekhov
Biomedicines.2023; 11(9): 2361. CrossRef
Impact of Diet on Colorectal Cancer Progression and Prevention: From Nutrients to Neoplasms
Sang Hoon Kim, Dong Hwan Park, Yun Jeong Lim
The Korean Journal of Gastroenterology.2023; 82(2): 73. CrossRef
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Shafiul Haque, Ritu Raina, Nazia Afroze, Arif Hussain, Ahmad Alsulimani, Vineeta Singh, Bhartendu Nath Mishra, Sanjana Kaul, Ravindra Nath Kharwar
Seminars in Cancer Biology.2022; 86: 666. CrossRef
A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies
Kimia Ghasemi, Kosar Ghasemi
European Journal of Pharmacology.2022; 916: 174593. CrossRef
Association Between H. pylori Infection and Colorectal Polyps: A Meta-Analysis of Observational Studies
Depeng Lu, Mingyu Wang, Xiquan Ke, Qiangwu Wang, Jianchao Wang, Dapeng Li, Meng Wang, Qizhi Wang
Frontiers in Medicine.2022;[Epub] CrossRef
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
Sang Hoon Kim, Yun Jeong Lim
Intestinal Research.2022; 20(1): 31. CrossRef
A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer
Nancy Scott, Emma Whittle, Patricio Jeraldo, Nicholas Chia
Neoplasia.2022; 29: 100797. CrossRef
Ficus dubia Latex Extract Induces Cell Cycle Arrest and Apoptosis by Regulating the NF-κB Pathway in Inflammatory Human Colorectal Cancer Cell Lines
Rentong Hu, Weerachai Chantana, Pornsiri Pitchakarn, Subhawat Subhawa, Bhanumas Chantarasuwan, Piya Temviriyanukul, Teera Chewonarin
Cancers.2022; 14(11): 2665. CrossRef
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Saptadip Samanta
Anti-Cancer Agents in Medicinal Chemistry.2022; 22(4): 605. CrossRef
Archaeome in Colorectal Cancer: High Abundance of Methanogenic Archaea in Colorectal Cancer Patients
Hosseinali Abdi, Dor Mohammad Kordi-Tamandani, Milad Lagzian, Alireza Bakhshipour
International Journal of Cancer Management.2022;[Epub] CrossRef
Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship
Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Mohammad Reza Alivand, Bita Sepehri, Simin Sotoodeh, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee
Current Pharmaceutical Biotechnology.2022; 23(10): 1257. CrossRef
Synthesis and Evaluation of Some New 4H-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations
Nahed N. E. El-Sayed, Magdi E. A. Zaki, Sami A. Al-Hussain, Abir Ben Bacha, Malika Berredjem, Vijay H. Masand, Zainab M. Almarhoon, Hanaa S. Omar
Pharmaceuticals.2022; 15(7): 891. CrossRef
Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Jung Won Lee, Chang Soo Eun
The Korean Journal of Internal Medicine.2022; 37(5): 885. CrossRef
The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia—A Narrative Review
Ida J. Malesza, Joanna Bartkowiak-Wieczorek, Jakub Winkler-Galicki, Aleksandra Nowicka, Dominika Dzięciołowska, Marta Błaszczyk, Paulina Gajniak, Karolina Słowińska, Leszek Niepolski, Jarosław Walkowiak, Edyta Mądry
Nutrients.2022; 14(17): 3478. CrossRef
Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment
Yun Liu, Jun Xu, Xinhua Ren, Yu Zhang, Ziliang Ke, Jianhua Zhou, Yang Wang, Yifan Zhang, Yulan Liu
Gut Microbes.2022;[Epub] CrossRef
Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment
Wenli Qiu, Tianqing Sang, Haibin Chen, Hongli Zhou, Zhongqiu Wang, Hongguang Zhou
Frontiers in Oncology.2022;[Epub] CrossRef
Roles of Gut Microbiota in Colorectal Carcinogenesis Providing a Perspective for Early Diagnosis and Treatment
Roghayeh Nouri, Alka Hasani, Mohammad Asgharzadeh, Fatemeh Yeganeh Sefidan, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee
Current Pharmaceutical Biotechnology.2022; 23(13): 1569. CrossRef
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
Wei Jia, Cynthia Rajani, Hongxi Xu, Xiaojiao Zheng
Protein & Cell.2021; 12(5): 374. CrossRef
Toll-like receptor 4 prevents AOM/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice
Yen-Peng Lee, Wen-Ching Huang, Tien-Jen Lin, Chien-Chao Chiu, Yu-Chih Wang, Yi-Hsun Chen, Shao-Wen Hung, Hsiao-Li Chuang, Ter-Hsin Chen
Human & Experimental Toxicology.2021; 40(4): 622. CrossRef
Gut microbiota influence tumor development and Alter interactions with the human immune system
Yanshan Ge, Xinhui Wang, Yali Guo, Junting Yan, Aliya Abuduwaili, Kasimujiang Aximujiang, Jie Yan, Minghua Wu
Journal of Experimental & Clinical Cancer Research.2021;[Epub] CrossRef
The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
Zhenxing Ren, Cynthia Rajani, Wei Jia
Cancers.2021; 13(4): 720. CrossRef
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer
Yongshun Ma, Yao Zhang, Houxiang Jiang, Shixin Xiang, Yueshui Zhao, Mintao Xiao, Fukuan Du, Huijiao Ji, Parham Jabbarzadeh Kaboli, Xu Wu, Mingxing Li, Qinglian Wen, Jing Shen, Zhongming Yang, Jing Li, Zhangang Xiao
Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
Analysis of the intestinal microbiome in colorectal cancer
B I Gataullin, I G Gataullin, Nguyen Thi Nga, A I Kolpakov, O N Ilinskaya
Kazan medical journal.2021; 102(2): 185. CrossRef
Astragalin Inhibits the Proliferation and Migration of Human Colon Cancer HCT116 Cells by Regulating the NF-κB Signaling Pathway
Min Yang, Wen-Yun Li, Jing Xie, Zi-Lin Wang, Yan-Long Wen, Cun-Chao Zhao, Liang Tao, Ling-Fei Li, Yang Tian, Jun Sheng
Frontiers in Pharmacology.2021;[Epub] CrossRef
Temporal metabolic response yields a dynamic biosignature of inflammation
Jesse T. Peach, Stephanie M. Wilson, Logan D. Gunderson, Lizzi Frothingham, Tan Tran, Seth T. Walk, Carl J. Yeoman, Brian Bothner, Mary P. Miles
iScience.2021; 24(8): 102817. CrossRef
Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers
Chuan-Yin Fang, Jung-Sheng Chen, Bing-Mu Hsu, Bashir Hussain, Jagat Rathod, Kuo-Hsin Lee
Microorganisms.2021; 9(8): 1548. CrossRef
Association of Helicobacter pylori infection with colorectal adenoma in the Chinese urban population: A cross-sectional study
Lingyu Shen, Rongwen Bian, Wei Wang, Junning Zhao
Microbial Pathogenesis.2021; 158: 105111. CrossRef
Multi-scale network targeting: A holistic systems-biology approach to cancer treatment
Doru Paul, Natalia L. Komarova
Progress in Biophysics and Molecular Biology.2021; 165: 72. CrossRef
Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of krasV12 in Transgenic Zebrafish
Jeng-Wei Lu, Yuxi Sun, Pei-Shi Angelina Fong, Liang-In Lin, Dong Liu, Zhiyuan Gong
Biomedicines.2021; 9(8): 974. CrossRef
High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients
Nasibeh Khodaverdi, Habib Zeighami, Ahmad Jalilvand, Fakhri Haghi, Negar Hesami
BMC Cancer.2021;[Epub] CrossRef
Function of BCLAF1 in human disease (Review)
Zongdong Yu, Jie Zhu, Haibiao Wang, Hong Li, Xiaofeng Jin
Oncology Letters.2021;[Epub] CrossRef
Association Between Carotid Ultrasonography Findings and Colorectal Adenoma in Asymptomatic Adults
Jeongseok Kim, Ji Young Lee, Nam Seok Ham, Eun Hye Oh, Hye-Sook Chang, Hyewon Park, Yoon Suh Do, Sung Wook Hwang, Dong-Hoon Yang, Jae Won Choe, Jeong-Sik Byeon
Digestive Diseases and Sciences.2020; 65(6): 1816. CrossRef
Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates Clostridioides difficile Colonization
Matthew K. Schnizlein, Kimberly C. Vendrov, Summer J. Edwards, Eric C. Martens, Vincent B. Young, Katherine McMahon
mSphere.2020;[Epub] CrossRef
Enterotoxigenic Bacteroides fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions
Samin Zamani, Reza Taslimi, Akram Sarabi, Seyedesomaye Jasemi, Leonardo A. Sechi, Mohammad Mehdi Feizabadi
Frontiers in Cellular and Infection Microbiology.2020;[Epub] CrossRef
Risk for Colorectal Neoplasia in Patients With Helicobacter pylori Infection: A Systematic Review and Meta-analysis
Da Sol Choi, Seung In Seo, Woon Geon Shin, Chan Hyuk Park
Clinical and Translational Gastroenterology.2020; 11(2): e00127. CrossRef
Metaproteomics characterizes human gut microbiome function in colorectal cancer
Shuping Long, Yi Yang, Chengpin Shen, Yiwen Wang, Anmei Deng, Qin Qin, Liang Qiao
npj Biofilms and Microbiomes.2020;[Epub] CrossRef
Gut commensal bacteria, Paneth cells and their relations to radiation enteropathy
Yan-Li Gao, Li-Hong Shao, Li-Hua Dong, Peng-Yu Chang
World Journal of Stem Cells.2020; 12(3): 188. CrossRef
Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer
Huizhe Wu, Wenyan Qin, Senxu Lu, Xiufang Wang, Jing Zhang, Tong Sun, Xiaoyun Hu, Yalun Li, Qiuchen Chen, Yuanhe Wang, Haishan Zhao, Haiyan Piao, Rui Zhang, Minjie Wei
Molecular Cancer.2020;[Epub] CrossRef
The Influence of Caerulomycin A on the Intestinal Microbiota in SD Rats
Hongwei Zhang, Mengmeng Lan, Guodong Cui, Weiming Zhu
Marine Drugs.2020; 18(5): 277. CrossRef
Influence of Iron on the Gut Microbiota in Colorectal Cancer
Oliver Phipps, Hafid O. Al-Hassi, Mohammed N. Quraishi, Aditi Kumar, Matthew J. Brookes
Nutrients.2020; 12(9): 2512. CrossRef
Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients
Congmin Xu, Qiong Jia, Lu Zhang, Zhe Wang, Shiwei Zhu, Xiaoqi Wang, Yixuan Liu, Mo Li, Jingjing Zhang, Xiangqun Wang, Jindong Zhang, Qinghua Sun, Kun Wang, Huaiqiu Zhu, Liping Duan
Frontiers in Cellular and Infection Microbiology.2020;[Epub] CrossRef
The Human OncoBiome Database: A Database of Cancer Microbiome Datasets
Nadia, Jayashree Ramana
Current Bioinformatics.2020; 15(5): 472. CrossRef
Microbiota and gastrointestinal cancer
Meng-Tzu Weng, Yu-Tse Chiu, Ping-Ya Wei, Chien-Wei Chiang, Huei-Ling Fang, Shu-Chen Wei
Journal of the Formosan Medical Association.2019; 118: S32. CrossRef
Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models
Susan J. Robertson, Paul Lemire, Heather Maughan, Ashleigh Goethel, Williams Turpin, Larbi Bedrani, David S. Guttman, Kenneth Croitoru, Stephen E. Girardin, Dana J. Philpott
Cell Reports.2019; 27(6): 1910. CrossRef
Periodontitis is associated with an increased risk for proximal colorectal neoplasms
Gun Woo Kim, Young-Sang Kim, Soo Hyun Lee, Seung Geon Park, Duk Hwan Kim, Joo Young Cho, Ki Baik Hahm, Sung Pyo Hong, Jun-Hwan Yoo
Scientific Reports.2019;[Epub] CrossRef
Physical Activity and Inflammation Phenotype Conversion
Mary P. Miles, Stephanie Wilson, Carl J. Yeoman
Journal of Clinical Exercise Physiology.2019; 8(2): 64. CrossRef
The clinical application of fruquintinib on colorectal cancer
Zhongguang Chen, Lili Jiang
Expert Review of Clinical Pharmacology.2019; 12(8): 713. CrossRef
Study Insights into Gastrointestinal Cancer through the Gut Microbiota
Fanli Kong, Yi Cai
BioMed Research International.2019; 2019: 1. CrossRef
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
Fausto Petrelli, Michele Ghidini, Antonio Ghidini, Gianluca Perego, Mary Cabiddu, Shelize Khakoo, Emanuela Oggionni, Chiara Abeni, Jens Claus Hahne, Gianluca Tomasello, Alberto Zaniboni
Cancers.2019; 11(8): 1174. CrossRef
Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer
Wenyan Qin, Xiaodong Wang, Yilin Wang, Yalun Li, Qiuchen Chen, Xiaoyun Hu, Zhikun Wu, Pengfei Zhao, Shanqiong Li, Haishan Zhao, Weifan Yao, Jian Ding, Minjie Wei, Huizhe Wu
Cancer Cell International.2019;[Epub] CrossRef
The association between fecal enterotoxigenic B. fragilis with colorectal cancer
Fakhri Haghi, Elshan Goli, Bahman Mirzaei, Habib Zeighami
BMC Cancer.2019;[Epub] CrossRef
Fusobacterium nucleatum and the Immune System in Colorectal Cancer
Elena Monica Borroni, Dorina Qehajaj, Floriana Maria Farina, Daniel Yiu, Robert S. Bresalier, Maurizio Chiriva-Internati, Leonardo Mirandola, Sanja Štifter, Luigi Laghi, Fabio Grizzi
Current Colorectal Cancer Reports.2019; 15(5): 149. CrossRef
Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros
Metabolism.2018; 87: A10. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Intestinal microbiota, chronic inflammation, and colorectal cancer

Intest Res. 2018;16(3):338-345. Published online July 27, 2018

DOI: https://doi.org/10.5217/ir.2018.16.3.338

XML Download

Figure

Related articles

The practice of fecal microbiota transplantation in inflammatory bowel disease

Intestinal microbiota, chronic inflammation, and colorectal cancer

Fig. 1 The proposed pathogenesis of colorectal carcinogenesis. MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor-κB; PI3K/AKT, phosphoinositide 3-kinase/protein kinase B; TNF-α, tumor necrosis factor α; IL, interleukin.

Fig. 1

Intestinal microbiota, chronic inflammation, and colorectal cancer